Department of Medicine

Department of Medicine

  Division of Cardiology

[Return To Index page]
photo Andrew H. Voigt, MD

Associate Professor, University of Pittsburgh School of Medicine


Phone: 412-647-6272

Office: Cardiovascular Institute, UPMC Presbyterian
200 Lothrop Street, PUH, Room B-535
Pittsburgh, PA 15213
Phone: 412-647-6272
Fax: 412-647-7979
Education and Training
BA, Dartmouth College, 1994
MD, University of Pittsburgh School of Medicine, 1998
Internship, Georgetown University Hospital, 1999
Residency, Georgetown University Hospital, 2001
Cardiology Fellowship, University of Pittsburgh, 2005
Cardiac Electrophysiology Fellowship, University of Pittsburgh, 2007
Research Interest
Dr. Voigt's research interests include cryoablation for atrial fibrillation and patterns of cardiovascular implantable electronic device utilization. He was one of the earliest physicians in the United States to implant a leadless pacemaker during a "first in human" multicenter trial.
Clinical Interest
Dr. Voigt's clinical interests include comprehensive management of atrial fibrillation in its paroxsymal and persistent forms. Another focus is catheter ablation for atrial fibrillation (AF), supraventricular tachycardia (SVT), and ventricular tachycardia (VT). He is engaged in the implantation and follow up of cardiovascular implantable electronic devices such as biventricular pacemakers and defibrillators (ICDs). He has implanted leadless pacemakers. In addition, his practice encompasses chronic management of pacemaker and defibrillator leads, including extraction.
Educational Interest
Dr. Voigt is engaged in teaching of medical residents and fellows.
For my complete bibliography, Click Here.
Selected Publications:
Voigt A, Ezzeddine R, Barrington W, Obiaha-Ngwu O, Ganz LI, London B, Saba S. Utilization of Implantable Cardioverter-Defibrillators in Survivors of Cardiac Arrest in the United States from 1996 to 2001. J Am Coll Cardiol. 2004; 44(4): 855-858.
Voigt A, Shalaby A, Saba S. Increasing Rates of Cardiac Rhythm Management Device Infections in the United States from 1996 to 2003. J Am Coll Cardiol. 2006; 48(3): 590-591.
Saba S, Ravipati LP, Voigt A. Recent trends in utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States. PACE. 2009; 32: 1444-1449.
Voigt A, Shalaby A, Adelstein E, Saba S. Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy. Clin Cardiol. 2010; 33(7): E1-5.
Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol. 2010; 33(4): 414-419.
RItter P, Duray GZ, Steinwender C, Soejima K, Omar R, Mont L, Boersma LV, Knops RE, Chinitz L, Zhang S, Narasimhan C, Hummel J, Lloyd M, Simmers TA, Voigt A, Laager V, Stromberg K, Bonner M, Shelton TJ, Reynolds D. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J. 2015; 36(37): 2510-2519.
Seriwals HM, Khan MS, Munir MB, Riaz IB, Riaz H, Saba S, Voigt AH. Leadless pacemakers: A new era in cardiac pacing. J Cardiol. 2016; 67(1): 1-5.
Singh M, Wang NC, Jain S, Voigt A, Saba S, Adelstein EC. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: A decade-long single center experience. J Am Coll Cardiol. 2015; 66(23): 2607-2613.
Wang NC, Singh M, Adelstein EC, Jain SK, Mendenhall GS, Shalaby AA, Voigt AH, Saba S. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study. Heart Rhythm. 2016; 0: 1-10.